Magdalena Zaborowska-Szmi (Magdalena Zaborowska-Szmit)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 15

Top Topics

Tyrosine Kinase

Neoadjuvant Chemotherapy

Cardiovascular Disease

Top Venues

Current oncology (Toronto, Ont.)

Journal of clinical medicine

Translational lung cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Dariusz Mirosław Kowalski, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Maciej Krzakowski
The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity. Translational lung cancer research 13 (6) (2024)
Dariusz Mirosław Kowalski, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Maciej Krzakowski
The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity. Translational lung cancer research 13 (6) (2024)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wroblewska, Piotr Jaśkiewicz, Adam Płużański, Maciej Krzakowski, Dariusz Mirosław Kowalski
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy. Cancers 15 (4) (2023)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wroblewska, Piotr Jaśkiewicz, Adam Płużański, Maciej Krzakowski, Dariusz Mirosław Kowalski
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy. Cancers 15 (4) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Aleksandra Piórek, Adam Płużański, Kinga Winiarczyk, Magdalena Zaborowska-Szmi, Katarzyna Zajda, Dariusz Mirosław Kowalski, Maciej Krzakowski
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice. Journal of clinical medicine 12 (6) (2023)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Aleksandra Piórek, Adam Płużański, Kinga Winiarczyk, Magdalena Zaborowska-Szmi, Katarzyna Zajda, Dariusz Mirosław Kowalski, Maciej Krzakowski
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice. Journal of clinical medicine 12 (6) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Maciej Krzakowski, Dariusz Mirosław Kowalski
Savolitinib for non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 59 (1) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wroblewska, Piotr Jaśkiewicz, Adam Płużański, Maciej Krzakowski, Dariusz Mirosław Kowalski
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy. Cancers 15 (4) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Aleksandra Piórek, Adam Płużański, Kinga Winiarczyk, Magdalena Zaborowska-Szmi, Katarzyna Zajda, Dariusz Mirosław Kowalski, Maciej Krzakowski
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice. Journal of clinical medicine 12 (6) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)